Correction
Antiproliferative effects of imatinib mesylate on ZR-75-1 and MDA-MB-231 cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF expression
Paper Information
Record ID:
24726
Author(s):
Journal:
Publication Date:
March 27, 2018
Retraction Date:
March 04, 2019
(6.7 years years ago)
Subjects:
Institutions:
- Department of Pharmacy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
- Department of Pharmacology and Therapeutics, School of Medicine, Faculty of Health and Medical Sciences, Taylor’s University, 47500 Subang Jaya, Malaysia
- Faculty of Medicine, Shiraz University of Medical Sciences (SUMS), Shiraz 71348-14336, Iran
- Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), 14176-13151 Tehran, Iran
Countries:
Article Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Correction Details
Citations (3)
3
Total Citations2
Post-Retraction(66.7%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
2
After 2+ years
2018
Days since retraction (latest)
Paper citing Antiproliferative effects of imatinib mesylate on ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Antiproliferative effects of imatinib mesylate on ...
Unknown Authors
Unknown Journal
Published: Sep 2024
2018 days after retraction
Paper citing Antiproliferative effects of imatinib mesylate on ...
Unknown Authors
Unknown Journal
Published: Jul 2024
1954 days after retraction
Quick Stats
Total Citations:
3
Years Since Retraction:
6.7 years
Open Access:
Yes
Last Checked:
Never